<DOC>
	<DOC>NCT00262548</DOC>
	<brief_summary>The purpose of this study is to determine whether treatment with rosuvastatin for 6 months in obese type 2 diabetic women will improve their lipid profiles and thus prevent the progression to cardiovascular disease.</brief_summary>
	<brief_title>C-Reactive Protein (CRP) in Obese Diabetic Women</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Menopausal Diagnosed diabetes mellitus type 2 Obese (body mass index [BMI] &gt; 25 ≤ 30) Fasting blood glucose ≥ 200 mg/dl CRP &lt; 2 mg/L and &gt; 10 mg/L</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Menopause</keyword>
</DOC>